Physician profile
Amer Raza
NPI 1295926533
$4,880.87
in general payments reported to CMS, 2019-2025
31 companies · $1,321 in 2025
The $1,321 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,044 · 2020: $225 · 2021: $307 · 2022: $730 · 2023: $454 · 2024: $801 · 2025: $1,321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,542 · Education: $33.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,541.91 |
| Education | $33.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $886.62 | 2021-2025 | |
| Glaxosmithkline, LLC. | $768.47 | 2019-2025 | Trelegy Ellipta, Nucala |
| Regeneron Healthcare Solutions, INC. | $589.50 | 2019-2025 | Dupixent |
| Getinge USA Sales, LLC | $404.98 | 2019-2021 | |
| United Therapeutics Corporation | $316.06 | 2019-2023 | Tyvaso |
| Astrazeneca Pharmaceuticals LP | $230.75 | 2019-2025 | Breztri |
| Mylan Specialty L.P. | $191.43 | 2019-2024 | Yupelri |
| Abbott Laboratories | $139.45 | 2025 | Aveir, Gallant, Jot Dx |
| Insmed, INC. | $131.36 | 2023-2025 | Arikayce |
| Intuitive Surgical, INC. | $123.75 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.70 | 2019-2025 | Jascayd, Ofev |
| Mallinckrodt Hospital Products INC. | $104.12 | 2023-2025 | Acthar |
| Amgen INC. | $94.21 | 2022-2025 | Tezspire |
| Actelion Pharmaceuticals US, INC. | $89.23 | 2019 | |
| Janssen Pharmaceuticals, INC | $81.46 | 2020-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $76.73 | 2019 | |
| Philips North America LLC | $67.35 | 2023-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Grifols USA, LLC | $56.12 | 2020-2025 | Prolastin-C Liquid |
| Allergan, INC. | $54.75 | 2019 | |
| Astellas Pharma US INC | $54.59 | 2019-2022 | |
| Viatris Specialty LLC | $49.69 | 2025 | Yupelri |
| Abiomed | $36.67 | 2022-2024 | Impella |
| Baxter Healthcare | $33.89 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Ethicon INC. | $30.92 | 2022 | |
| Merck Sharp & Dohme LLC | $28.28 | 2025 | Winrevair |
| Medtronic, INC. | $28.21 | 2023-2025 | Illumisite |
| Ambu INC. | $25.09 | 2023 | |
| Csl Behring | $24.46 | 2020 | |
| Tactile Systems Technology INC | $21.02 | 2024 | Flexitouch Plus, Entre Plus |
| Verona Pharma, INC. | $17.12 | 2025 | Ohtuvayre |
| Circassia INC. | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amer Raza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.